Top Section
Explore Business Standard
Don’t miss the latest developments in business and finance.
Book Building
₹ 3042.62
₹ 549
27
₹ 14,823.00
MumbaiNSE
11-Dec-2024
13-Dec-2024
18-Dec-2024
Initial public offering of 55,421,123 equity shares of face value of Re. 1 each (Equity Shares) of Sai Life Sciences Limited (The Company or the Company) for cash at a price of Rs. 549 per equity share (including a premium of Rs. 548 per equity share) (Offer Price) aggregating to Rs. 3042.62 crores (the Offer) comprising a fresh issue of 17,304,189 equity shares of face value of Re. 1 each aggregating to Rs. 950.00 crores (the Fresh Issue) and an offer for sale of 38,116,934 equity shares of face value of Re. 1 each aggregating to Rs. 2092.62 crores (the Offer for Sale), consisting of 6,454,780 equity shares of face value of Re. 1 each aggregating to Rs. 354.37 crores by Sai Qest Syn Private Limited (Promoter Selling Shareholder), 23,159,368 equity shares of face value of Re. 1 each aggregating to Rs. 1271.45 crores by tpg asia vii sf pte ltd (TPG), 6,210,186 equity shares of face value of Re. 1 each aggregating to Rs. 340.94 crores by hbm private equity india (collectively with tpg, Investor Selling Shareholders) and 2,292,600 equity shares of face value of Re. 1 each aggregating to Rs. 125.86 crores by certain persons listed in this prospectus (the Other Selling Shareholders, as defined below) (the promoter selling shareholder, investor selling shareholders and other selling shareholders, the Selling Shareholders and such equity shares, the Offered Shares).
Repayment/prepayment in full or part of all or certain outstanding borrowings availed by the company. General corporate purposes.
Sai Life Sciences Ltd, Karvy Selenium Tow-B, 31&32 Financial Dist, Nanakramguda, Hyderabad-500032
Phone - 91-40-67162222
Fax - 91-40-23001153/23420814
Email - investors@sailife.com
Website - www.sailife.com